Loading…

In Vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells

Polyalkyl cyanoacrylate nanoparticles were previously developed as a biodegradable, ultrafine, solid drug carrier. Distribution studies in the rat showed an intense and rapid hepatic uptake. This liver accumulation appears to represent, to a certain extent, extracellularly bound nanoparticles. Durin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 1984-07, Vol.73 (7), p.980-982
Main Authors: Lenaerts, V., Nagelkerke, J. F., Van Berkel, T. J. C., Couvreur, P., Grislain, L., Roland, M., Speiser, P.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polyalkyl cyanoacrylate nanoparticles were previously developed as a biodegradable, ultrafine, solid drug carrier. Distribution studies in the rat showed an intense and rapid hepatic uptake. This liver accumulation appears to represent, to a certain extent, extracellularly bound nanoparticles. During liver perfusion, 15–20% of the liver‐associated nanoparticles were washed out. The cellular distribution of strongly cell‐associated nanoparticles was determined. At different intervals after injection of radioactive nanoparticles to rats, the cells were isolated according to a recently developed, low‐temperature procedure during which processing of the carrier was inhibited. At all tested times, a relatively intense capture by Kupffer cells in comparison with endothelial and especially parenchymal cells was observed. This distribution pattern was not influenced by the size of the nanoparticles (0.08–0.215‐μm diameter). This specific‐interaction of nanoparticles with Kupffer cells opens possibilities for the treatment of some parasitic diseases involving this cell type.
ISSN:0022-3549
1520-6017
DOI:10.1002/jps.2600730730